John W. Newcomer
John W. Newcomer
President and CEO, Thriving Mind South Florida
Verified email at - Homepage
Cited by
Cited by
Consensus development conference on antipsychotic drugs and obesity and diabetes
American Diabetes Association
Diabetes care 27 (2), 596-601, 2004
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
M De Hert, CU Correll, J Bobes, M Cetkovich-Bakmas, DAN Cohen, I Asai, ...
World psychiatry 10 (1), 52, 2011
Second-generation (atypical) antipsychotics and metabolic effects
JW Newcomer
CNS drugs 19 (1), 1-93, 2005
NMDA receptor hypofunction model of schizophrenia
JW Olney, JW Newcomer, NB Farber
Journal of psychiatric research 33 (6), 523-533, 1999
Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level
M De Hert, DAN Cohen, J Bobes, M Cetkovich-Bakmas, S Leucht, ...
World psychiatry 10 (2), 138, 2011
Decreased memory performance in healthy humans induced by stress-level cortisol treatment
JW Newcomer, G Selke, AK Melson, T Hershey, S Craft, K Richards, ...
Archives of general psychiatry 56 (6), 527-533, 1999
Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia
JW Newcomer, DW Haupt, R Fucetola, AK Melson, JA Schweiger, ...
Archives of general psychiatry 59 (4), 337-345, 2002
Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis
JW Newcomer, NB Farber, V Jevtovic-Todorovic, G Selke, AK Melson, ...
Neuropsychopharmacology 20 (2), 106-118, 1999
Glucocorticoid-induced impairment in declarative memory performance in adult humans
JW Newcomer, S Craft, T Hershey, K Askins, ME Bardgett
Journal of Neuroscience 14 (4), 2047-2053, 1994
Antipsychotic medications: metabolic and cardiovascular risk
JW Newcomer
Journal of Clinical Psychiatry 64 (4), 8-13, 2007
Metabolic considerations in the use of antipsychotic medications: a review of recent evidence
MD Britton Ashley Arey
J Clin Psychiatry 68 (1), 20-27, 2007
Memory improvement following induced hyperinsulinemia in Alzheimer's disease
S Craft, J Newcomer, S Kanne, S Dagogo-Jack, P Cryer, Y Sheline, ...
Neurobiology of aging 17 (1), 123-130, 1996
Severe mental illness and risk of cardiovascular disease
JW Newcomer, CH Hennekens
Jama 298 (15), 1794-1796, 2007
Antipsychotic-induced weight gain and metabolic abnormalities: implications for increased mortality in patients with schizophrenia
DE Casey, DW Haupt, JW Newcomer, DC Henderson, MJ Sernyak, ...
J Clin Psychiatry 65 (Suppl 7), 4-18, 2004
Obesity among those with mental disorders: a National Institute of Mental Health meeting report
DB Allison, JW Newcomer, AL Dunn, JA Blumenthal, AN Fabricatore, ...
American journal of preventive medicine 36 (4), 341-350, 2009
Comorbid somatic illnesses in patients with severe mental disorders: clinical, policy, and research challenges
WW Fleischhacker, M Cetkovich-Bakmas, M De Hert, CH Hennekens, ...
The Journal of clinical psychiatry 69 (4), 0-0, 2008
The metabolic effects of antipsychotic medications
JW Newcomer, DW Haupt
The Canadian Journal of Psychiatry 51 (8), 480-491, 2006
Enhancement of memory in Alzheimer disease with insulin and somatostatin, but not glucose
S Craft, S Asthana, JW Newcomer, CW Wilkinson, IT Matos, LD Baker, ...
Archives of general psychiatry 56 (12), 1135-1140, 1999
Metabolic syndrome and mental illness
JW Newcomer
American Journal of managed care 13 (7), S170, 2007
Hyperglycemia and antipsychotic medications
DW Haupt, JW Newcomer
Journal of Clinical Psychiatry 62 (27), 15-26, 2001
The system can't perform the operation now. Try again later.
Articles 1–20